Profile and outcome of neuroblastoma with conventional chemotherapy in children older than one year: A 15-years experience

Indian Pediatrics

Volumn 45, Issue 2, 2008, Pages 135-139

  Bansal, Deepak ^a   Marwaha, R K ^a   Trehan, Amita ^a   Rao, K L N ^a   Gupta, Vishal ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

India; Neuroblastoma; Survival; Treatment

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHILD; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROBLASTOMA; SEX RATIO; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR GROWTH;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUROBLASTOMA;

EID: 40349089866     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Brodeur GM, Maris JM. Neuroblastoma. In: Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology, 5th edn. Philadelphia: Lippincott Williams & Wilkins: 2006 p. 933-970.
2. Nickerson HJ, Matthay KK, Seeger RC, Brodeur GM, Shimada H, Perez C, et al. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: A Children's Cancer Group Study. J Clin Oncol 2000; 18: 477-486.
3. Laprie A, Michon J, Hartmann O, Munzer C, Leclair MD, Coze C, et al. Neuroblastoma Study Group of the French Society of Pediatric Oncology. High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification. Cancer 2004; 101: 1081-1089.
4. Pritchard J, Cotterill SJ, Germond SM, Imeson J, de Kraker J, Jones DR. High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group. Pediatr Blood Cancer 2005; 44: 348-357.
5. Tsuchida Y, Shitara T, Kuroiwa M, Ikeda H. Current treatment and future directions in neuroblastoma. Indian J Pediatr 2003; 70: 809-812.
6. Kusumakumari P, Ajithkumar TV, Ratheesan K, Chellam VG, Nair MK. Pattern and outcome of neuroblastoma. A 10 year study. Indian Pediatr 1998; 35: 223-229.
7. Kusumakumari P, Ajithkumar TV, Hariharan S, Varma RR, Chellam VG, Nair R, et al. Intensive chemotherapy in children with stage IV neuroblastoma. Indian J Pediatr 1999; 66: 867-872.
8. Rao SR, Iyer RS, Nair CN, Kurkure PA, Pai SK, Advani SH. Infantile neuroblastoma: 10 year TMH experience. Indian J Cancer 1993; 30: 85-87.
9. Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D'Angio G, et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 1988; 6: 1874-1881.
10. Marwaha RK, Choudhry VP. Neuroblastoma in Indian Children. Indian J Pediatr 1982; 49: 811-813.
11. Frappaz D, Michon J, Coze C, Berger C, Plouvier E, Lasset C, et al. LMCE3 treatment strategy: Results in 99 consecutively diagnosed stage 4 neuroblastomas in children older than 1 year at diagnosis. J Clin Oncol 2000; 18: 468-476.
12. Ng SM, Abdullah WA, Lin HP, Chan LL. Presenting features and treatment outcome of 78 Malaysian children with neuroblastoma. Southeast Asian J Trop Med Public Health 1999; 30: 149-153.
13. Olgun N, Kansoy S, Aksoylar S, Cetingul N, Vergin C, Oniz H, et al. Experience of the Izmir Pediatric Oncology Group on Neuroblastoma: IPOG-NBL-92 Protocol. Pediatr Hematol Oncol 2003; 20: 211-218.
14. Leung CK. Fifteen years' review of advanced childhood neuroblastoma from a single institution in Hong Kong. Chin Med J (Engl) 1998; 111: 466-469.
15. Posner JB. Paraneoplastic syndromes in neuroblastoma. J Pediatr Hematol Oncol 2004; 26: 553-554.
16. Altman AJ, Baehner RL. Favorable prognosis for survival in children with coincident opsomyoclonus and neuroblastoma. Cancer 1976; 37: 846-852.
17. Ingram L, River G, Shapiro DDN. Superior vena cava syndrome associated with childhood malignancy. Analysis of 24 cases. Med Pediatr Oncol 1990; 18: 476.
18. Shah S, Ravindranath Y. Neuroblastoma. Indian J Pediatr 1998; 65: 691-705.
19. Castel V, Canete A. A comparison of current neuroblastoma chemotherapeutics. Expert Opin Pharmacother 2004; 5: 71-80.
20. Matthay KK, Tan JC, Villablanca JG, Yanik GA, Veatch J, Franc B, et al. Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approach to Neuroblastoma Therapy Consortium Study. J Clin Oncol 2006; 24: 500-506.
21. Nathan PC, Furlong W, De Pauw S, Horsman J, Van Schaik C, Rolland M, et al. Health status of young children during therapy for advanced neuroblastoma. Pediatr Blood Cancer 2004; 43: 659-667.